Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

5α-reductase inhibitors for hair loss can cause mild, reversible sexual side effects in some men.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.